Search

Your search keyword '"Blank, Christian"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Blank, Christian" Remove constraint Author: "Blank, Christian" Topic t cells Remove constraint Topic: t cells
23 results on '"Blank, Christian"'

Search Results

1. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

3. Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.

4. Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

5. Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

6. Metabolic profiles of regulatory T cells in the tumour microenvironment.

7. Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

8. Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single‐centre experience in patients with BRAF‐mutated melanoma.

9. Mimicking homeostatic proliferation in vitro generates T cells with high anti-tumor function in non-lymphopenic hosts.

10. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8+ T cells.

11. The "cancer immunogram".

12. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

13. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.

14. Immune resistance orchestrated by the tumor microenvironment.

15. Negative Regulation of T-Cell Function by PD-1.

16. Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.

17. Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.

18. Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.

19. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

20. Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

21. PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis

22. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

23. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Catalog

Books, media, physical & digital resources